615.665.7100
Board of Directors
BreatheAmerica Board of Directors consists of five individuals all of whom have extensive experience in executive and board of director roles throughout the health care field. Board members include:
Lucius E. Burch III
Chairman and CEO of Burch Investment Group.
E. Townes Duncan
Managing Partner Solidus Company, LP
Joseph C. Hutts
Chairman and CEO BreatheAmerica, Inc.
Richard E. Ragsdale
Founder Community Health Systems (Retired)
Derril W. Reeves
Chief Development Officer, BreatheAmerica, Inc.
Immunotherapy helps reduce hay fever symptoms in about 85% of people with allergic rhinitis.
In one study, 55% of patients with sinusitis also had a history of allergic rhinitis.
Asthma accounts for approximately 500,000 hospitalizations each year.
The annual economic cost of asthma is $19.7 billion. Direct costs make up $14.7 billion of that total, and indirect costs such as lost productivity add another $5 billion.